Pharmaceutical manufacturing

FILE- This Nov. 14, 2018, file photo shows Lubriderm, a Johnson & Johnson product, on display at a market in Pittsburgh. Johnson & Johnson reports financial results on Tuesday, July 16. (AP Photo/Gene J. Puskar, File)
July 16, 2019 - 10:58 am
Johnson & Johnson posted slightly lower sales across much of its business in the second quarter, but a big one-time gain and lower spending on marketing and administration boosted its profit a whopping 42 percent. That blew past Wall Street expectations. The maker of baby shampoo and cancer and...
Read More
FILE - In this June 6, 2019, file photo specialist John Parisi, left, works with traders on the floor of the New York Stock Exchange. The U.S. stock market opens at 9:30 a.m. EDT on Friday, July 12. (AP Photo/Richard Drew, File)
July 12, 2019 - 3:29 pm
NEW YORK (AP) — U.S. stocks were modestly higher in afternoon trading on Friday, as declines in health care stocks were offset by gains in technology, consumer discretionary and industrial company stocks. The gains came a day after the Dow Jones Industrial Average closed above 27,000 points for the...
Read More
President Donald Trump speaks about kidney health at the Ronald Reagan Building and International Trade Center, accompanied by Health and Human Services Secretary Alex Azar, left, Wednesday, July 10, 2019, in Washington. (AP Photo/Alex Brandon)
July 11, 2019 - 10:33 am
WASHINGTON (AP) — President Donald Trump is withdrawing a plan to ease the financial bite of costly medications for people on Medicare by letting them to receive rebates that drugmakers now pay to insurers and middlemen, the White House said Thursday. The once-highly promoted plan from Health and...
Read More
FILE - In this Oct. 25, 2018, file photo, President Donald Trump talks about drug prices during a visit to the Department of Health and Human Services in Washington. A federal judge Monday, July 8, 2019, blocked a major White House initiative on prescription drug costs, saying the Trump administration lacked the legal authority to require drugmakers to disclose their prices in TV ads. (AP Photo/Susan Walsh, File)
July 08, 2019 - 10:51 pm
WASHINGTON (AP) — A federal judge Monday blocked a major White House initiative on prescription drug costs, saying the Trump administration lacked the legal authority to require drugmakers to disclose their prices in TV ads. The narrow ruling by U.S. District Judge Amit Mehta in Washington, D.C.,...
Read More
President Donald Trump talks to reporters on the South Lawn of the White House before departing for his Bedminster, N.J. golf club, Friday, July 5, 2019, in Washington. (AP Photo/Evan Vucci)
July 05, 2019 - 1:04 pm
WASHINGTON (AP) — President Donald Trump is promising an executive order that he says is intended to enable the U.S. government to pay lower prices for prescription drugs. Trump says his administration soon would announce a "favored-nations clause," where the amount paid by the government for a...
Read More
FILE - In this June 20, 2019, file photo traders gather at a post on the floor of the New York Stock Exchange as they wait for the Slack Technologies IPO to begin trading. Stocks are off to a mixed start on Wall Street on Monday, June 24, as gains for technology companies are offset by losses in health care and other sectors. (AP Photo/Richard Drew, File)
June 24, 2019 - 3:47 pm
Health care companies helped pull the broader stock market slightly lower Monday in a day of listless trading on Wall Street as investors focused on upcoming trade talks between the U.S. and China. The major stock indexes drifted between small gains and losses for much of the day, though smaller...
Read More
FILE - This Dec. 4, 2017, file photo shows the Pfizer company logo at the company's headquarters in New York. Pfizer is buying the cancer treatment company Array BioPharma in a deal worth $11.4 billion. Array has a combination therapy for BRAF-mutant metastatic melanoma, along with a pipeline of targeted cancer medicines in development and a portfolio of other medicines that are expected to generate significant royalties over time. (AP Photo/Richard Drewm Fuke, File)
June 17, 2019 - 8:28 am
NEW YORK (AP) — Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing positive clinical trial results earlier this spring. Pfizer said Monday it will pay $48 per share in cash for Array,...
Read More
June 14, 2019 - 5:38 am
BERLIN (AP) — German chemical and pharmaceutical company Bayer says it plans to invest some 5 billion euros ($5.6 billion) over the next decade in developing "additional methods to combat weeds." Friday's announcement came as Bayer is engaged in legal battles in the U.S. in which plaintiffs claim...
Read More
This March 26, 2018 photo provided by Ashley Atwater shows her mother, Sally Atwater, outside her home in the Georgetown area of Washington, a few days after leaving the hospital. Atwater's doctor spent two months on calls, messages and dozens of pages of forms to get her an experimental drug he thinks can fight the lung cancer that has spread to her brain and spine. (Courtesy Ashley Atwater via AP)
June 03, 2019 - 9:59 am
CHICAGO (AP) — Sally Atwater's doctor spent two months on calls, messages and paperwork to get her an experimental drug he thinks can fight the lung cancer that has spread to her brain and spine. Nancy Goodman begged eight companies to let her young son try experimental medicines for a brain tumor...
Read More
May 20, 2019 - 3:12 pm
WASHINGTON (AP) — The Supreme Court said Monday that a judge must decide whether a dispute between drugmaker Merck and patients who alleged they were injured by its bone-strengthening drug Fosamax can go forward. All nine justices agreed that the case should go back to a lower court for further...
Read More

Pages